Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$696M |
| 2 |
Moderna
MRNA
|
+$487M |
| 3 |
Analog Devices
ADI
|
+$272M |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$261M |
| 5 |
Tesla
TSLA
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$670M |
| 2 |
Microsoft
MSFT
|
+$376M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$335M |
| 4 |
Alibaba
BABA
|
+$323M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.45% |
| 2 | Healthcare | 13.43% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Village Farms International
VFF
$311M
| $1.72M | ﹤0.01% |
+205,598
| New | +$1.92M |
|
|
SURF
3077
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $1.72M | ﹤0.01% |
226,540
+67,243
| +42% | +$430K |
|
3078
Distribution Solutions Group
DSGR
$1.61B
| $1.71M | ﹤0.01% |
68,428
+1,920
| +3% | +$50.3K |
|
3079
FRP Holdings
FRPH
$426M
| $1.71M | ﹤0.01% |
60,978
+4,046
| +7% | +$116K |
|
3080
Akebia Therapeutics
AKBA
$241M
| $1.7M | ﹤0.01% |
591,829
+29,674
| +5% | +$84.7K |
|
3081
Honda
HMC
$40.7B
| $1.7M | ﹤0.01% |
55,560
+1,868
| +3% | +$58.8K |
|
|
ZIXI
3082
DELISTED
Zix Corporation
ZIXI
| $1.7M | ﹤0.01% |
241,086
+16,833
| +8% | +$122K |
|
3083
Keros Therapeutics
KROS
$200M
| $1.7M | ﹤0.01% |
42,955
+4,595
| +12% | +$164K |
|
|
VAPO
3084
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $1.7M | ﹤0.01% |
9,541
+790
| +9% | +$161K |
|
|
VIEW
3085
DELISTED
View, Inc. Class A Common Stock
VIEW
| $1.7M | ﹤0.01% |
5,220
+1,222
| +31% | +$429K |
|
|
AUD
3086
DELISTED
Audacy, Inc.
AUD
| $1.69M | ﹤0.01% |
458,477
+38,884
| +9% | +$136K |
|
3087
Lifestance Health
LFST
$4.85B
| $1.69M | ﹤0.01% |
+116,295
| New | +$2.24M |
|
|
HUYA
3088
Huya Inc
HUYA
$529M
| $1.69M | ﹤0.01% |
202,100
+19,748
| +11% | +$228K |
|
|
CLVS
3089
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.68M | ﹤0.01% |
377,296
+77,023
| +26% | +$371K |
|
|
GTHX
3090
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.68M | ﹤0.01% |
125,250
+10,424
| +9% | +$170K |
|
3091
Viking Therapeutics
VKTX
$3.85B
| $1.67M | ﹤0.01% |
266,352
+16,191
| +6% | +$100K |
|
3092
HSBC
HSBC
$356B
| $1.67M | ﹤0.01% |
63,823
-1,099
| -2% | -$29.9K |
|
3093
Tiptree Inc
TIPT
$675M
| $1.67M | ﹤0.01% |
166,454
+17,540
| +12% | +$172K |
|
|
BCOV
3094
DELISTED
Brightcove, Inc.
BCOV
| $1.67M | ﹤0.01% |
144,547
+9,633
| +7% | +$116K |
|
3095
NWPX Infrastructure Inc
NWPX
$1.12B
| $1.67M | ﹤0.01% |
70,321
+1,641
| +2% | +$43.4K |
|
|
CODX
3096
Co-Diagnostics
CODX
$5.16M
| $1.66M | ﹤0.01% |
5,686
+764
| +16% | +$223K |
|
3097
Doximity
DOCS
$4.47B
| $1.66M | ﹤0.01% |
+20,568
| New | +$1.5M |
|
3098
Banco Santander
SAN
$209B
| $1.66M | ﹤0.01% |
458,201
-83,984
| -15% | -$310K |
|
|
KDNY
3099
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.65M | ﹤0.01% |
129,599
+12,280
| +10% | +$162K |
|
3100
Blue Owl Capital
OWL
$19.1B
| $1.65M | ﹤0.01% |
+106,175
| New | +$1.47M |
|
Similar funds
Bank of New York Mellon's Q3 2021 Portfolio in Review
As of Q3 2021, Bank of New York Mellon held 4,634 positions worth $512B, down 0.89% from $517B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of New York Mellon's Q3 2021 filing shows 243 new, 2,575 increased, 1,388 reduced and 114 closed positions. Its largest new stake was GXO Logistics: 863,863 shares worth $67.8M. The largest sale was Apple, an estimated $670M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q3 2021 buy was GXO Logistics: 863,863 shares worth $67.8M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q3 2021, an estimated $696M increase.
- Bank of New York Mellon's biggest Q3 2021 reduction was Apple, cutting an estimated $670M.
- Bank of New York Mellon fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $335M.
- Bank of New York Mellon's ten largest holdings make up 20% of its $512B portfolio in Q3 2021.
- Bank of New York Mellon opened 243 new positions and closed 114 in Q3 2021.
- Bank of New York Mellon's portfolio value fell 0.89% quarter-over-quarter to $512B.
Based on Bank of New York Mellon's 13F filing for Q3 2021, filed 12 Nov 2021.